Raul Santos Gave 2 Talks at SAC 2025: On The Role of LDL-C and Future of Lipid-lowering Therapies
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn:
”I had the privilege of giving two talks at the Argentinian Society of Cardiology (SAC) congress in Buenos Aires.
The first talk focused on the role of LDL-C in atherosclerosis, presenting overwhelming data and evidence to support this understanding.
It was great to work with Drs. Melina Huerin and Walter Masson on this.
The second talk explored the future of lipid-lowering therapies, highlighting the role of genetics in paving the way for newer therapies targeting LDL, triglycerides, and Lp(a).
Additionally, I had the opportunity to collaborate with Pablo Corral on a meeting with colleagues from the Argentinian Lipid Society (SAL).
During this meeting, we discussed the current challenges in reducing the burden of ASCVD and explored potential actions to address the residual risk associated with various factors, including LDL-C, Lp(a), triglycerides, inflammation, obesity, and thrombosis.
Many good things will come in the near future.
I’d like to thank SAC and Novartis Argentina for the opportunity.”
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction